Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

May 07, 2019, 05:30 ET Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


May 06, 2019, 16:25 ET CannTrust to Report First Quarter 2019 Results

VAUGHAN, ON, May 6, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX:TRST, NYSE:CTST) will release its financial results for...


May 06, 2019, 16:15 ET CannTrust Closes Previously Announced Public Offering

VAUGHAN, ON, May 6, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX:TRST, NYSE:CTST) announced today the closing of its...


May 06, 2019, 09:19 ET Skyhawk Therapeutics Announces Agreement with Takeda to Develop Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases

Skyhawk Therapeutics, Inc. (Skyhawk) today announced a strategic collaboration with Takeda Pharmaceutical Company Limited (Takeda) in which Skyhawk...


May 06, 2019, 07:00 ET Bausch Health Companies Inc. Announces First-Quarter 2019 Results And Raises Full-Year Guidance

First-Quarter 2019 Financial Results Revenues of $2.016 Billion GAAP Net Loss of $52 Million GAAP Cash Flow From Operations of $413 Million in line...


May 06, 2019, 07:00 ET Aurora Cannabis to Host Third Quarter 2019 Investor Conference Call on May 15, 2019

TSX: ACB | NYSE: ACB EDMONTON, May 6, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN:...


May 06, 2019, 05:00 ET Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201

Connect Biopharma today announced that it has successfully completed a phase 1 single ascending dose (SAD) study of its novel IL-4Rα antibody,...


May 06, 2019, 05:00 ET Does your Dog Have Itchy Ears?

GUELPH, ON, May 6, 2019 /CNW/ - Does your dog shake their head frequently, scratch incessantly at their ears or have smelly, dirty or itchy ears? In...


May 04, 2019, 16:00 ET Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting

HOUSTON, TX and VANCOUVER, May 4, 2019 /CNW/ - ESSA Pharma Inc. (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel...


May 04, 2019, 12:00 ET Lung cancer: less invasive surgery for faster recovery

A CRCHUM researcher paves the way for the widespread use of this new operation MONTREAL, May 4, 2019 /CNW Telbec/ - Every day, 78 Canadians receive a ...


May 03, 2019, 17:15 ET The Italian R&D Excellence at the American Urological Association's 2019 Annual Meeting

Eighteen out of 20 enrolled patients completed the 12-week intensive course. Instillations were very well tolerated; no patients withdrew from the...


May 03, 2019, 07:00 ET Canopy Rivers congratulates TerrAscend on receiving its EU GMP certification and new distribution agreement

TORONTO, May 3, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company...


May 02, 2019, 16:05 ET Pivot Pharma Issues Statement on California Operations

VANCOUVER, May 2, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") announces that it filed a protective...


May 02, 2019, 10:30 ET AKL Research & Development and Nordic Bioscience Collaborate to Take Novel Osteoarthritis Medicine to Phase II

AKL Research & Development (AKLRD) and Nordic Bioscience Clinical Development, today announce a risk-share agreement to assess the efficacy of a...


May 02, 2019, 09:35 ET Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial

Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, has received acceptance from the Haute Autorité de Santé (HAS, ...


May 02, 2019, 09:00 ET Six World-Class Medical Pioneers Join the Canadian Medical Hall of Fame

LONDON, ON, May 2, 2019 /CNW/ - On Thursday, May 2, the Canadian Medical Hall of Fame (CMHF) will induct six new Laureates whose contributions have...


May 02, 2019, 08:00 ET CROP'S Tenant Hempire Receives Cultivation and Extraction License in Oklahoma

CROP Infrastructure Corp. (CSE: CROP) (CSE: CROP.CN) (OTC: CRXPF) (Frankfurt: 2FR) announced today that its first Oklahoma farm's tenant, Hempire...


May 02, 2019, 01:15 ET CRESEMBA™ now available in Canada for the treatment of invasive aspergillosis and invasive mucormycosis

BLAINVILLE, QC, May 2, 2019 /CNW Telbec/ - AVIR Pharma Inc. (AVIR), is pleased to announce that Cresemba™ (isavuconazole, as isavuconazonium...


May 01, 2019, 17:35 ET Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection, USP Due to the Presence of a Glass Fragment Observed in One Vial of Reconstituted Product

Endo International plc, announced today that one of its operating companies, Par Pharmaceutical, Inc., is voluntarily recalling one lot of...


May 01, 2019, 17:27 ET Kneat Appoints SaaS Industry Veteran, Rory Cameron, as New Board Member

HALIFAX, May 1, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that Mr. Rory Cameron has been appointed to its Board of...


May 01, 2019, 11:43 ET Three Mefloquine lawsuits filed against Government of Canada

TORONTO, May 1, 2019 /CNW/ - Three separate lawsuits have been filed in the Federal Court by a total of 8 individuals against the Government of...


May 01, 2019, 08:05 ET Panaxia and Rafa sign a collaboration agreement with PlantEXT to research and manufacture the first medical cannabis suppositories intended for patients suffering from inflammatory bowel disease ("IBD", Crohn's and colitis)

Panaxia Pharmaceutical Industries Israel and the pharmaceutical company Rafa, announced the signing of a collaboration agreement with PlantEXT Ltd.,...


May 01, 2019, 08:00 ET Correvio to Report First Quarter 2019 Financial Results on May 8, 2019

Conference Call Scheduled for Wednesday, May 8, 2019 at 8:30 a.m. Eastern (5:30 a.m. Pacific) NASDAQ: CORV TSX: CORV VANCOUVER, May 1, 2019 /CNW/ -...


May 01, 2019, 07:00 ET Bausch + Lomb Canada Supports Moments that Matter with the 'Why Eye Care' Campaign for Vision Health Month

One share = $1 investment to Fighting Blindness Canada TORONTO, May 1, 2019 /CNW Telbec/ - This May, for Vision Health Month, Bausch + Lomb Canada is ...


Apr 30, 2019, 15:54 ET Geyser Brands' 2nd Harvest Complete, 3rd Harvest Yield to Increase 200% in Preparation for Solace Acquisition

Company expands reach across the value chain to ensure quality, consistency of raw materials for R&D and subsidiaries /THIS NEWS RELEASE, PROVIDED...